Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Fagan

Showing results (431-440 of 451) with videos related to

Pageof 46
Sort By:
International Journal of Cardiology|May 21, 2022
Surgical outcomes of pulmonary valve infective endocarditis: A US population-based analysisYesh Datar, Kanhua Yin, Yunda Wang, et al.
Advanced Materials (Deerfield Beach, Fla.)|August 28, 2010
Carbon nanotubes: measuring dispersion and lengthJeffrey A Fagan, Barry J Bauer, Erik K Hobbie, et al.
American Journal of Physiology. Lung Cellular and Molecular Physiology|December 20, 2011
Cytoskeletal defects in Bmpr2-associated pulmonary arterial hypertensionJennifer A Johnson, Anna R Hemnes, Daniel S Perrien, et al.
Environmental Science & Technology|April 7, 2016
Quantification of Carbon Nanotubes in Environmental Matrices: Current Capabilities, Case Studies, and Future ProspectsElijah J Petersen, D Xanat Flores-Cervantes, Thomas D Bucheli, et al.
Science (New York, N.Y.)|May 23, 2020
Precise pitch-scaling of carbon nanotube arrays within three-dimensional DNA nanotrenchesWei Sun, Jie Shen, Zhao Zhao, et al.
Langmuir : the ACS Journal of Surfaces and Colloids|April 30, 2008
Comparison of the quality of aqueous dispersions of single wall carbon nanotubes using surfactants and biomoleculesReto Haggenmueller, Sameer S Rahatekar, Jeffrey A Fagan, et al.
Chest|April 10, 2015
Sensitivity Analyses of the Change in FVC in a Phase 3 Trial of Pirfenidone for Idiopathic Pulmonary FibrosisDavid J Lederer, Williamson Z Bradford, Elizabeth A Fagan, et al.
ACS Nano|March 10, 2020
Bright Silicon Nanocrystals from a Liquid Precursor: Quasi-Direct Recombination with High Quantum YieldTodd A Pringle, Katharine I Hunter, Alexandra Brumberg, et al.
The New England Journal of Medicine|May 20, 2014
A phase 3 trial of pirfenidone in patients with idiopathic pulmonary fibrosisTalmadge E King, Williamson Z Bradford, Socorro Castro-Bernardini, et al.
The European Respiratory Journal|December 10, 2015
Pirfenidone for idiopathic pulmonary fibrosis: analysis of pooled data from three multinational phase 3 trialsPaul W Noble, Carlo Albera, Williamson Z Bradford, et al.
Pageof 46

Showing results (431-440 of 451) with videos related to

Sort By:
Pageof 46
International Journal of Cardiology|May 21, 2022
Surgical outcomes of pulmonary valve infective endocarditis: A US population-based analysisYesh Datar, Kanhua Yin, Yunda Wang, et al.
Advanced Materials (Deerfield Beach, Fla.)|August 28, 2010
Carbon nanotubes: measuring dispersion and lengthJeffrey A Fagan, Barry J Bauer, Erik K Hobbie, et al.
American Journal of Physiology. Lung Cellular and Molecular Physiology|December 20, 2011
Cytoskeletal defects in Bmpr2-associated pulmonary arterial hypertensionJennifer A Johnson, Anna R Hemnes, Daniel S Perrien, et al.
Environmental Science & Technology|April 7, 2016
Quantification of Carbon Nanotubes in Environmental Matrices: Current Capabilities, Case Studies, and Future ProspectsElijah J Petersen, D Xanat Flores-Cervantes, Thomas D Bucheli, et al.
Science (New York, N.Y.)|May 23, 2020
Precise pitch-scaling of carbon nanotube arrays within three-dimensional DNA nanotrenchesWei Sun, Jie Shen, Zhao Zhao, et al.
Langmuir : the ACS Journal of Surfaces and Colloids|April 30, 2008
Comparison of the quality of aqueous dispersions of single wall carbon nanotubes using surfactants and biomoleculesReto Haggenmueller, Sameer S Rahatekar, Jeffrey A Fagan, et al.
Chest|April 10, 2015
Sensitivity Analyses of the Change in FVC in a Phase 3 Trial of Pirfenidone for Idiopathic Pulmonary FibrosisDavid J Lederer, Williamson Z Bradford, Elizabeth A Fagan, et al.
ACS Nano|March 10, 2020
Bright Silicon Nanocrystals from a Liquid Precursor: Quasi-Direct Recombination with High Quantum YieldTodd A Pringle, Katharine I Hunter, Alexandra Brumberg, et al.
The New England Journal of Medicine|May 20, 2014
A phase 3 trial of pirfenidone in patients with idiopathic pulmonary fibrosisTalmadge E King, Williamson Z Bradford, Socorro Castro-Bernardini, et al.
The European Respiratory Journal|December 10, 2015
Pirfenidone for idiopathic pulmonary fibrosis: analysis of pooled data from three multinational phase 3 trialsPaul W Noble, Carlo Albera, Williamson Z Bradford, et al.
Pageof 46